Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alto Neuroscience
Biotech
Biogen CMO heads for the exits
Biogen's head of development, Priya Singhal, is the interim CMO following Maha Radhakrishnan's exit.
Max Bayer
Mar 15, 2024 10:51am
Alto, Fractyl head to public markets with IPOs north of $100M
Feb 2, 2024 8:14am
Alto aims for $101M IPO to pave neuro development climb
Jan 30, 2024 11:37am
Alto Neuroscience preps IPO to push CNS therapies through clinic
Jan 16, 2024 6:51am
Alto's 2nd precision psychiatry med improves depression symptoms
Dec 4, 2023 5:00pm
Biotech pipeline hosts 163 potential meds for mental illness
Jan 30, 2023 5:30am